Moore Alison
CIK 0001754937
President and CEODirector
Filings
15
Latest Feb 25, 2026
Issuers covered
3
Showing
15 of 15
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +7.7% | +6.0% | +22.8% | -5.8% |
| 90 days | 3 | 33% | -24.9% | -13.5% | +32.8% | -94.0% |
| 180 days | 2 | 50% | -38.9% | -38.9% | +8.0% | -85.9% |
| 365 days | 1 | 100% | +27.4% | +27.4% | +27.4% | +27.4% |
Issuers
Companies where Moore Alison has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CDXS | Codexis, Inc. | 9 | Feb 25, 2026 |
| ALLO | Allogene Therapeutics, Inc. | 4 | Mar 24, 2023 |
| ARTV | Artiva Biotherapeutics, Inc. | 2 | Jun 26, 2025 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|